Lipoprotein-Associated Phospholipase A2 - Pathophysiological Role and Clinical Significance as a Cardiovascular Biomarker
Within the last decade, a broad range of biomarkers associated with an increased risk for death and cardiovascular/cerebrovascular endpoints have been identified. Epidemiological studies clearly indicate that lipoprotein-associated phospholipase A2 (Lp-PLA2) has the potential to become clinically us...
Saved in:
Main Authors: | Stankovic, Sanja (Author), Asanin, Milika (Author) |
---|---|
Format: | Ebooks |
Published: |
IntechOpen,
2015-10-07.
|
Subjects: | |
Online Access: | Get Online |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Differences of Lipoprotein-Associated Phospholipase A2, Apolipoprotein B and Low Density Lipoprotein In Obese and Lean Men
by: Yuliana, Yuliana, et al.
Published: (2021) -
Diagnostic Value of Lipoprotein (a) in Cardiovascular
by: Yanuartono, Yanuartono, et al.
Published: (2014) -
Pathophysiology of Lipoprotein Oxidation
by: Jairam, Vikram, et al.
Published: (2012) -
The adrenergic system in cardiovascular physiology and pathophysiology
by: Giuseppe Rengo
Published: (2015) -
The Adrenergic System in Cardiovascular Physiology and Pathophysiology, 2nd Edition
by: Giuseppe Rengo
Published: (2015)